Further work is being undertaken to finalise the costs of implementing these plans, and to refine the modelling and assumptions that underlie them. This will take account of the investment made to date in improving cancer and diagnostic services and new models of delivery.
Initial estimates are as follows:
Capital costs will be about £650 million between the periods 2011-12 and 2014-15; and
Early estimates of revenue costs are in the region of £1,250 million between the periods 2011-12 and 2015-16. (This corrects my written answer given to the hon. Member for South Cambridgeshire on 13 October 2009, Official Report, column 802W in which it was stated that the revenue costs were for the period 2011-12 and 2014-15).
Final costing requirements and profiling will be worked up over the coming months in consultation with the national health service taking into account new models of delivery and changes in working practices.